4-trans-(NN-Dimethylamino)cinnamaldehyde (an aldehyde, DACA) and 4-trans-(NN-dimethylamino)cinnamoylimidazole (an amide, DACI) have been shown to be substrates for human aldehyde dehydrogenase (EC 1.2.1.3) which form chromophoric covalent intermediates. The spectra of covalent intermediates from both the cytoplasmic (El) and mitochondrial (E2) isoenzymes derived from DACA and DACI were compared. The spectra were similar when either substrate was used, and also when the two isoenzymes were compared, and resembled that obtained for 4-trans-(NNdimethylamino)cinnamoyl-N-acetylcysteine, but differed from the spectrum of 4-trans-(NN-dimethylamino)cinnamoyl ethyl ester. After extensive digestion of the covalent intermediates from both 3H-labelled DACA and DACI with Pronase and purification, the labelled amino acid was identified as cysteine. Covalent intermediates from both DACA and DACI were also digested with trypsin, and labelled peptides were purified by ion-exchange and reverse-phase chromatography. Amino acid sequence analysis showed that the peptide comprising residues 273-307 was labelled by both DACA and DACI. The radioactive label at cysteine residues 301-303 of the primary structure could be unequivocally identified by employing the DACA derivative. Assignment of label to cysteine-302 was achieved by employing iodoacetamide-labelled El isoenzyme (iodoacetamide specifically labels cysteine-302), in which case there was no formation of the covalent intermediate from either DACA or DACI. In addition, cysteine-302 is the only cysteine residue conserved in all aldehyde dehydrogenases sequenced. Thus cysteine-302 is the amino acid residue that forms a covalent intermediate with both aldehyde and ester substrates.
INTRODUCTION
Aldehyde dehydrogenase (EC 1.2.1.3) catalyses dehydrogenation of aldehydes and hydrolysis of esters via a covalent intermediate, which was postulated to be a thioester (Jakoby, 1963) . Human aldehyde dehydrogenase isoenzymes El and E2 were first purified in our laboratory in 1977 (Greenfield & Pietruszko, 1977) ; in the 1980s both isoenzymes were sequenced (Hempel et al., 1984 . Chemical modification with iodoacetamide identified a super-reactive cysteine residue, later found to be residue 302, in a complete amino acid sequence (Hempel, 1981; Hempel & Pietruszko, 1981; Hempel et al., 1982a; Hempel et al., 1984 Hempel et al., , 1985 . Since total inactivation was not achieved (Hempel & Pietruszko, 1981) , cysteine-302 could not be unequivocally assigned to the active site. The use of coenzyme analogues determined cysteine-369 and -302 to be near the coenzyme-binding site (von Bahr-Lindstrom et al., 1985) . Chemical modification work with N-ethylmaleimide claimed to have identified cysteine-49 and -162 as part of the active site of aldehyde dehydrogenase (Tu & Weiner, 1988a,b) . Our laboratory developed an aldehyde substrate-based affinity reagent, bromoacetophenone (MacKerell et al., 1986) , and used it to identify glutamate-268 (Abriola et al., 1987) . Bromoacetophenone also labelled cysteine-302 (Abriola et al., 1990) , and in conjunction with another study employing a vinyl ketone affinity reagent , assignment of cysteine-302 to the active site could finally be made.
The above work, however, could not resolve the issue of residue functionality. It was proposed that aldehyde dehydrogenase mechanism involved acylation of a different group from that involved in hydrolysis of esters (Kitson, 1978; MacGibbon et al., 1978; Deady et al., 1985) . Tu & Weiner (1988a,b) concluded that aldehyde dehydrogenation proceeded at cysteine-49, whereas ester hydrolysis proceeded at cysteine-162. Duncan (1985) has argued for a single-site model; other evidence in support of a single-site model includes reports of reversal of the reaction to produce acetaldehyde from 4-nitrophenyl acetate and NADH (Duncan, 1979 ; Loomes & Kitson, 1986) . Loomes et al. (1990) , employing the aldehyde substrate 4-trans-(NN-dimethylamino) cinnamaldehyde (DACA), proposed serine-74 as a candidate for the catalytic residue for aldehyde dehydrogenation, whereas Kitson et al. (1991) identified cysteine-302 as the catalytic residue for ester hydrolysis.
The 4-trans-(NN-dimethylamino)cinnamoyl derivatives are highly chromophoric and were previously employed in studies of elastase catalysis (Breaux & Bender, 1976) as well as those of chymotrypsin and carboxypeptidase A (Hoffman et al., 1983; Weber et al., 1986) . In addition to work by Loomes et al. (1990) , DACA was used with sheep liver aldehyde dehydrogenase in rapid kinetic studies which resulted in observation of a transient reaction intermediate (Buckley & Dunn, 1982 , 1985 . Since the acyl group from DACA and 4-trans-(NN-dimethylamino)-cinnamoylimidazole (DACI) should be identical, identical covalent intermediates would be expected only if the same enzyme residue were involved in their formation. Thus, DACA and DACI, which were 3H-labelled for the present study, had a major advantage over chemical-modification reagents The El and E2 isoenzymes were purified to homogeneity as described by Hempel et al. (1982b) . Homogeneity was confirmed by isoelectric focusing and specific activity. Before use, the enzymes were subjected to gel filtration employing a Sephadex G-50 (fine grade) column (1.7 cm x 20 cm) equilibrated in sodium phosphate buffer (30 mm, pH 7.0, containing 1 mM-EDTA). Standard esterase and dehydrogenase activity assays and protein determinations were done as previously described (Abriola et al., 1990 Carboxymethylation and tryptic hydrolysis Carboxymethylation and tryptic digestion were performed by the method of Hempel & Pietruszko (1981) without prior reduction, since the labelled enzyme was unstable in 2-mercaptoethanol and dithiothreitol (Blatter, 1990) .
Purification of DACA-or DACI-labelled tryptic peptides by f.p.l.c.
The freeze-dried tryptic hydrolysate was dissolved in 5 mmpotassium phosphate buffer, pH 6.5, and applied to a Pharmacia Mono P column which had been equilibrated in this buffer. The column was washed for about 25 min (with a flow rate of 0.5 ml/min) with the same buffer, before initiation of a 40 min linear gradient to 1 M-KCl in 5 mM-potassium phosphate buffer, pH 6.5. Upon completion ofthe gradient, the radioactive material was eluted with acetic acid (1-2 M) or guanidinium chloride (3-6 M). After elution with acetic acid, pH adjustment was made by using ammonium hydroxide; the labelled peptide precipitated during pH adjustment.
Purification of DACI-labelled E2 tryptic peptides
Fractions containing radioactivity were scanned for u.v.-visible absorbance. After pH adjustment to pH 6.5-7.0, the precipitate was collected, dissolved in 1 M-acetic acid and applied to a C,8 ,tBondapak column and eluted with a gradient from 0.1 0% TFA to 100 % acetonitrile (80 min, linear gradient; flow rate: 1 ml/min). Further purification employed a diphenylbonded reverse-phase column and a gradient of 0.1 % TFA to 50 % acetonitrile (80 min, curved gradient, with a flow of 2 ml/min); the radioactive material separated into two peaks (fractions 12.5-14.0, containing 540o of the total radioactivity, and fractions 15.0-17.5, with 4600 of the total radioactivity).
(i) Purification of DACI-labelled peptide from fractions 12.5-14.0. Material from these fractions was chromatographed on a Supelco C4 (butyldimethyl) column, with a gradient of 0.1 %0, TFA to 500 acetonitrile (80 min, linear gradient, flow of 3 ml/min). The final two steps of purification involved chromatography on the diphenyl-bonded column, using first a gradient of 0.1 00 TFA to 1000 acetonitrile (40 min, linear gradient, flow of 2 ml/min) and finally a gradient of 0.1 00 TFA to 100 0 methanol (40 min, linear gradient, with a flow rate of 3 ml/min).
(ii) Purification of DACI-labelled peptide from fractions 15.0-17.5. This peptide was further purified using the C4 column and a gradient of 0.1 % TFA to 100 % acetonitrile (40 min, linear gradient, with a flow rate of 2.5 ml/min). The final chromatographic step employed the diphenyl-bonded column and a gradient of 0.1 /% TFA to 50 % acetonitrile (40 min, linear gradient, flow of 2 ml/min). N-Terminal sequencing and amino acid analysis N-Terminal sequencing was performed at the New York Blood Center, Laboratory of Microchemistry, as described by Abriola et al. (1990) . The initial yields of individual peptides were determined by extrapolating the repetitive yields of all component amino acids to zero time. Spurious assignment of peptide initial yields due to anomalously low or high levels of an amino acid in the initial sequencing cycles could therefore be avoided. When purification of the label-bearing peptide was only partial, sequence analysis resulted in multiple simultaneous sequences. These multiple sequences could be followed with some degree of reliability when different peptides occurred in different amounts; their identification was made easier by the availability of complete primary structures (Hempel et al., 1984 . Amino-acid-composition analysis was by the methods of Liu & Boykins (1989) and Heinrikson & Meredith (1984 Comparison of spectra of covalent intermediates formed from DACA and DACI
The absorption spectra of covalent intermediates derived from both the El and E2 isoenzymes were identical, within experimental error, with either DACA or DACI as substrate (see Table 3 . Sequence analysis of the I3HIDACA-labelled peptide from the E2 isozyme The position number in the E2 isoenzyme is given as a superscript to the amino acid . The amount of [3H]DACAlabelled tryptic peptide was 1.2 nmol (calculated from the specific radioactivity before sequencing).
Yield based on sequence
Position number and residues identified Peptide (pmol) (Xaa = unidentified) A 1000 273Ser-Pro-Xaa-lle-Ile-Met-Ser-Asp-Ala-AspMet-Asp-Trp-Ala-Val-Glu-Gln-His-Ala-PheAla-Leu-Phe-Phe-Asn-Gln-Gly-Gln-Xaa-XaaXaa-Ala-Gly-Ser306 B 1200 439Ala-Asn-Xaa-Leu-Ser-Gln-Ala-Leu-GlnXaa-Gly-Thr-Val-Xaa-Val-Asn-Xaa-Tyr-ValPhe-Gly-Xaa-Phe-Gly-Xaa-Gln-Ser-Pro464 '00Tyr-Thr-Xaa-Ala-Ala-Leu-Glu-Thr-XaaAsp-Xaa-Xaa-Lys..2 E 500
'Ala-Xaa-Gln-Ala-Val-Xaa-Ala-Pro-Asn-XaaGln-Pro-Glu-Xaa-Phe-Xaa-Xaa-Xaa-Ile-PheIle-Asn-Xaa-Glu-Trp28 Partial purification and sequence analysis of the 13HIDACA-labelled peptide of the E2 isoenzyme Although the stability of the covalent intermediate was better than expected, the number of steps required for purification to homogeneity reduced the yield of labelled peptide to the point where label localization was impossible. This necessitated the alternate approach of sequencing partially purified peptides. The [3H]DACA-labelled E2 isoenzyme, after tryptic digestion, was chromatographed on the Mono P column and eluted with 1 Macetic acid as a single sharp peak. Labelled material precipitated when the pH was adjusted to -6.5; the precipitate (1.2 nmol) was washed, dissolved in 0.1 % TFA (v/v in water), and sequenced. Protein sequencing identified a mixture of five peptides (see Table 3 ), A, B, C, D, and E, corresponding to residues 273-306, 439-464, 156-178, 100-112, and 4-28 respectively. The initial yields from the first cycle of sequencing of peptides A-D all corresponded to the amount of [3H]DACAlabelled peptide (calculated before sequencing from the amount of radioactive label); that of peptide E was about 500 less. By cycle 28, peptides C and D were completely sequenced, and peptides B and E were no longer detectable; only peptide A remained. No significant amount of radioactivity was detected in cycles 1-28 (Fig. 2) ; a large increase in radioactivity was observed in cycles 29-31, with the highest amount in cycle 29 (corresponding to cysteine-301 in aldehyde dehydrogenase). Purification and sequence analysis of the [3H]DACA-labelled peptide from the E2 isoenzyme was repeated twice. In expt. 2, the tryptic hydrolysate was chromatographed on a Pharmacia Superose 12 gel-filtration column equilibrated in 0.15 M-ammonium bicarbonate (Loomes et al., 1990) . Labelled fractions were combined and applied to a Waters C18 column equilibrated in 0.1 0% TFA.
Radioactive material was eluted at 26, 28, 30, and 39 min, with an 80 min linear gradient to 100 % methanol. The peak eluted at 39 min was further purified on a Supelco C8 column equilibrated in 0.1 0% TFA, and eluted as a single peak at 15.5 min with a 40 min linear gradient to 100 % acetonitrile, and sequenced. In expt. 2, the greatest amount of radioactivity also corresponded to cysteine-301. In expt. 3, the labelled material was eluted from the Mono P column with I M-acetic acid. The precipitation step was omitted; further purification employed two additional steps on a Supelco C4 column. In the first step, a 40 min linear gradient from 0.1 o TFA to 100 % methanol was used (a single radioactive peak was obtained at 19-20 min); and, in the second step, a 40 min linear gradient from 0.1 0% TFA to acetonitrile was used (the radioactivity was eluted as a single peak at 17 min). In expt. 3 the greatest amount of radioactive label corresponded to cysteine-302 and -303.
It can be seen from distribution of radioactivity in Fig. 2 that the label is not stable to sequencing conditions. A comparison of the amounts of derivatized cysteine in cycles that contained the most label showed that decomposition occurred during sequencing. Thus the amount of derivatized cysteine in cycle 29 (Fig. 2) Chromatography on the diphenyl reverse-phase column (see the Materials and methods section) separated the labelled material into two species: one peak in fractions 12.5-14.0 and another in fractions 15.0-17.5. Material from fractions 12.5-14.0 was purified to near-homogeneity (see Table 4 ), and identified by sequence analysis as the tryptic peptide spanning from residues 273-307 of the primary structure of the E2 enzyme. This peptide was sequenced in its entirety; the initial yield of the peptide was estimated to be -600-650 pmol from sequence analysis; that calculated from radioactivity was 540 pmol. Wash liquid from the sequencer was found to contain 48.5 %, and the sample disc and Teflon seal of the sequencer contained only 1.60 and 1.1 % of the original radioactivity respectively, indicating that decomposition had occurred. No significant levels of radioactivity were associated with any of the sequencing cycle fractions, although radioactivity was above background in all fractions. When material from fractions 15.0-17.5 was sequenced, a peptide beginning at residue 273 was identified as a minor component (Table 4 ). The amount of sample calculated to be present, based upon radioactivity, correlated best with this peptide, but there was insufficient material to obtain the entire sequence (sequencing was not continued past 14 cycles). Since this peptide eluted from the reverse-phase h.p.l.c. column at a later retention time than the first material purified, it appears likely that it was a partial cleavage product.
Pronase digestion of covalent intermediate formed from E2 isoenzyme and 13HIDACI
The precipitated E2-DACI adduct was subjected to Pronase digestion (see Table 5 ). The digested enzyme was applied to a C18 ,uBondapak reverse-phase column and eluted with a gradient of 0.1 % TFA to 1000% methanol (80 min, linear gradient, flow rate of 1.5 ml/min). A major peak of radioactivity was observed in fractions 37-38, which were eluted in a position distinct from that of DACA or the corresponding acid. DACI itself is acidlabile and decomposed under similar conditions of chromatography. Since Pronase has esterase activity and could have potentially hydrolysed the covalent intermediate, the time course of Pronase digestion was investigated over a period of 5-18 h by chromatography on a C18,, Bondapak column. It was found that labelled material in fractions 37-38 occurred at a maximal level at about 12-14 h. After Pronase digestion for 14 h, fraction 38, which contained the most label, was analysed for amino acid composition, as were side fractions (36 and 39). Aliquots were freeze-dried and subjected to hydrolysis with HCI with or without prior treatment with performic acid. Cysteic acid found in fraction 38 after performic acid oxidation was at the level expected from the specific radioactivity of the label (Table 5) ; side fractions which contained no radioactivity did not contain measurable amounts of cysteine. Other amino acids were found at low levels and/or were also present in side fractions. Results of analyses after HCI hydrolysis alone were comparable with those obtained where performic acid treatment was carried out, indicating no significant destruction of amino acids during oxidation. Pronase digestion was repeated, and the labelled material eluted from the C18 column was further purified by chromatography on a diphenyl-bonded reverse-phase column. Analysis of this material gave the same results (Table 5 ).
Pronase digestion of covalent intermediate from E2 isoenzyme and DACA
In a similar experiment, the E2 isoenzyme was modified with DACA in the presence of 0.5 mM-NAD' and digested, as Ser-Pro-Asn-Ile-Ile-Met-Ser-Asp-Ala-Asp-Metdiphenyl column* Asp-Trp-Ala-Val-Glu-Gln-Ala-His-Phe-AlaLeu-Phe-Phe-Asn-Gln-Gly-Gln-Xaa-Xaa-XaaAla-Gly-Ser-Arg (corresponding to residues 273-307 of the primary structure) 5-10
Gln-Ile-Ile-Pro-Trp-Asn-Phe-Pro-Leu-Leu (starting in ninth cycle of sequencing; corresponding to residues [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] Blatter, 1990) . The (Table 3) . Scintillation counting of the fractions eluted during the HCIhydrolysed and unhydrolysed (derivatized blank) sample gradients showed no significant peaks of radioactivity correlating with any phase of the gradient. effects of this modification on the formation of the covalent intermediate were tested. The El isoenzyme (4.6 ,uM) was incubated with 100 /tM-iodoacetamide in the presence of 1.5 itM-NADI in a total volume of 4 ml at pH 7.0. A control was incubated in the absence of iodoacetamide. After gel filtration, NADI and DACA or DACI were added to each sample and, after incubation for 100 s, the protein was precipitated and washed with water. The control reaction mixtures had a distinct yellow colour and gave a characteristic spectrum, whereas the iodoacetamide-modified protein samples remained colourless and showed no spectrum, indicating that iodoacetamide modification prevented formation of the covalent intermediates from both DACA and DACI.
DISCUSSION
The results presented (Table 1) demonstrate that DACA and DACI are substrates for human liver aldehyde dehydrogenase. Analogously to serine proteinases (Breaux & Bender, 1976) Fig. 1 ) demonstrates almost complete protection of chloral hydrate against formation of an intermediate from both DACA and DACI, suggesting strongly that only the active site of aldehyde dehydrogenase is involved in the reaction with both compounds.
The spectral properties of the covalent intermediates formed from the El and E2 isoenzymes and DACI were identical (within experimental error) with those of the covalent intermediates from DACA (Table 2 ). They resemble those of 4-trans-(NNdimethylamino)cinnamoyl thioesters and of 4-trans-(NNdimethylamino)cinnamoylimidazoles, but not those of the analogous oxygen esters or acids. Although the absorbance spectra of the covalent intermediates also resemble that of DACI, the possibility of reaction with histidine seems unlikely, since the DACI substrate itself is unstable to conditions of h.p.l.c., whereas the covalent intermediates were stable. The spectral properties were totally inconsistent with a covalent intermediate being formed with a hydroxy group (Loomes et al., 1990) .
Employing the E2-DACA derivative, the peptide corresponding to residues 273-307 was identified in three separate experiments, each using a different purification scheme. The peptide identified by Loomes et al. (1990) , comprising residues 68-77 (or any part of it) was not detected in any peptide mixture containing the label-bearing peptide derived from the E2 isoenzyme. Identification was the most unequivocal in the first experiment, since all impurities were shorter and sequenced out. In all experiments, the radioactive label was associated with residues 301-303. The first tryptic peptide from the E2-DACI derivative was identified by sequencing, as also was that comprising amino acid residues 273-307 of the primary structure (Table 4) . During sequencing of the second peptide, the radioactivity present in the sample correlated best with the same peptide (starting at residue 273), which was, however, contaminated with large amounts of other peptides. The peptide containing cysteine-162, which was postulated by Tu & Weiner (1988b) to be involved in ester hydrolysis, was a major component of the second peptide mixture (Table 4) , where it was present in amounts 30 times higher than that expected from the radioactive label. Thus, from our results, it appears unlikely that cysteine-162 could possibly participate in ester hydrolysis.
Further experiments involved digestion of the covalent intermediate derived from the E2 enzyme and DACA and DACI with Pronase. After digestion and chromatography, radioactively labelled material from both derivatives, when analysed for amino acid composition, was found to contain only cysteine in the amount expected from the specific radioactivity of the label (Table 5) (Lindahl & Hempel, 1990) . Thus cysteine-302 is the amino acid residue which participates in the formation of the covalent intermediate with both the aldehyde and ester substrates.
